These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9109176)

  • 21. Serotonergic function and self-injurious behavior in personality disorder patients.
    New AS; Trestman RL; Mitropoulou V; Benishay DS; Coccaro E; Silverman J; Siever LJ
    Psychiatry Res; 1997 Mar; 69(1):17-26. PubMed ID: 9080541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prolactin response to fenfluramine in impulsive aggression.
    New AS; Trestman RF; Mitropoulou V; Goodman M; Koenigsberg HH; Silverman J; Siever LJ
    J Psychiatr Res; 2004; 38(3):223-30. PubMed ID: 15003426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system serotonergic responsivity and aggressive disposition in men.
    Manuck SB; Flory JD; Muldoon MF; Ferrell RE
    Physiol Behav; 2002 Dec; 77(4-5):705-9. PubMed ID: 12527023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM; Pasatiempo AP; Yeung J; Cooper TB; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Sep; 43(3):263-76. PubMed ID: 1438624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.
    Coccaro EF; Lee R; Kavoussi RJ
    Neuropsychopharmacology; 2010 Jan; 35(2):435-44. PubMed ID: 19776731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample.
    Manuck SB; Flory JD; McCaffery JM; Matthews KA; Mann JJ; Muldoon MF
    Neuropsychopharmacology; 1998 Oct; 19(4):287-99. PubMed ID: 9718592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low HDL cholesterol, aggression and altered central serotonergic activity.
    Buydens-Branchey L; Branchey M; Hudson J; Fergeson P
    Psychiatry Res; 2000 Mar; 93(2):93-102. PubMed ID: 10725526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment?
    Dolan M; Deakin WJ; Roberts N; Anderson I
    Psychol Med; 2002 Jan; 32(1):105-17. PubMed ID: 11885567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.
    Coccaro EF; Kavoussi RJ; Hauger RL; Cooper TB; Ferris CF
    Arch Gen Psychiatry; 1998 Aug; 55(8):708-14. PubMed ID: 9707381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
    Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study.
    New AS; Gelernter J; Yovell Y; Trestman RL; Nielsen DA; Silverman J; Mitropoulou V; Siever LJ
    Am J Med Genet; 1998 Feb; 81(1):13-7. PubMed ID: 9514581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychobiological differences between the aggression and psychoticism dimension.
    Netter P; Hennig J; Rohrmann S
    Pharmacopsychiatry; 1999 Jan; 32(1):5-12. PubMed ID: 10071177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.